幽门螺杆菌响应Th1-IFN-γ免疫动态增减cagA拷贝数作为其致病性调控的新机制
批准号:
32100140
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
苏汉福
依托单位:
学科分类:
病原细菌学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
苏汉福
中文摘要
幽门螺杆菌(Hp)毒力因子CagA在胃炎、胃癌发生中起关键作用。我们已报道:Hp可携带多个cagA基因拷贝,通过同源重组增减拷贝数,显著改变Hp致病性,但Hp维持高拷贝数cagA的机制尚不明确。预实验显示:感染初期,cagA拷贝数无明显变化,高拷贝数cagA致病性显著增加;感染中后期,高拷贝数cagA减少,Hp致病性减弱,Th1-IFN-γ免疫可能是促cagA拷贝数减少的关键。据此我们推测:当Th1-IFN-γ免疫低下时,Hp可维持高拷贝数cagA而致病。本项目拟开展:通过不同cagA拷贝数Hp感染小鼠模型探讨cagA拷贝数调控Hp致病性的具体机制;利用免疫缺陷小鼠、细胞过继转移实验等明确IFN-γ的关键作用;最终由免疫抑制小鼠模型证实Th1-IFN-γ免疫低下时,Hp维持高拷贝数cagA而致病。本项目将完整阐明cagA拷贝数变化规律和致病机制,为防治Hp感染和相关胃部疾病提供科学依据。
英文摘要
Helicobacter pylori(Hp) transfers its virulence factor CagA into host cells, which plays a significant role in development of gastric disease such as gastritis and gastric cancer. In our previous studies, we showed that some Hp strains harbored multiple cagA gene copies, and Hp could change cagA copy number dynamically via homologous recombination, which also changed its pathogenicity significantly. However, the mechanism in which Hp kept higher number of cagA copies and being more pathogenic remains to be elucidated. In current study, we showed that higher cagA copy number induced more pathogenic phenotypes 4 weeks post infection in mice; however, the number of cagA copies decreased 8 weeks post infection, along with reduced pathogenic. We further showed that host adaptive immunity, probably Th1-IFN-γ, should be the key factor driving decrease of cagA copy number. Thus, we hypothesize that when Th1-IFN-γ immunity is hampered, Hp would keep high number of cagA copies and hence more virulent. In current study, we will first detail the process how change of cagA copy number regulates Hp pathogenicity in mice. Secondly, we will further confirm the key role of IFN-γ through multiple gene-engineered mice models and immune cell adoptive transfer. Finally, we will prove that when host adaptive immunity is impaired, Hp can keep high number of cagA copies and thus be more pathogenic. This study will clarify regulation of cagA copy number and conditions in which Hp keeps more cagA copies and be more virulent, providing evidence for Hp eradication and new clues for treatment of Hp related gastric diseases.
幽门螺杆菌(Hp)毒力因子CagA是公认的致癌蛋白。团队前期已报道,部分Hp菌株可携带多个cagA基因拷贝,且可在体外培养中动态变化拷贝数。然而,该基因型对Hp致病性的调控机制尚不明确。本研究旨在揭示Hp cagA基因拷贝数在不同宿主免疫状态下的动态变化及其对致病性的调控机制,重点探讨宿主特异性免疫的关键作用。通过构建野生型小鼠、Rag1-/-小鼠、Ifn-γ-/-小鼠及环孢菌素A(CsA)诱导的免疫功能低下小鼠感染模型,结合cagA基因拷贝数检测、致病性评估(IL-8分泌、细胞表型、组织HE染色)和免疫学分析,发现以下结果:在免疫正常小鼠中,Hp cagA拷贝数于感染后期(8周)显著减少,致病性减弱;而在免疫缺陷小鼠中,Hp通过维持或增加cagA拷贝数增强致病性。进一步证实特异性免疫中IFN-γ是驱动cagA拷贝数减少的关键宿主因素,且CsA诱导的特异性免疫功能低下时,Hp可维持高拷贝数cagA基因和高致病性,更易导致疾病发生发展。本项目明确了Hp cagA基因拷贝数及其动态变化调控T4SS-CagA致病性的具体机制,揭示了Hp维持高拷贝数cagA基因和高致病性的规律和条件,为临床Hp的治疗和相关疾病预防提供了新思路。研究结果不仅丰富了对Hp感染机制的认识,也为开发新的治疗策略提供了科学依据,具有重要的科学意义和应用前景。
国内基金
海外基金